Novoprotein Scientific Inc. (SHA:688137)
China flag China · Delayed Price · Currency is CNY
113.77
-3.83 (-3.26%)
At close: Nov 17, 2026

Novoprotein Scientific Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
725.46711.1647.35863.7929.92189.39
Short-Term Investments
-998.931,154404.51--
Trading Asset Securities
---621.7966.85-
Cash & Short-Term Investments
725.461,7101,8011,8901,897189.39
Cash Growth
-9.22%-5.07%-4.69%-0.36%901.50%101.86%
Accounts Receivable
64.661.7762.0279.97134.6696.58
Other Receivables
1.548.5510.913.4510.352.95
Receivables
66.1470.3272.9383.4214599.53
Inventory
84.7963.3276.0884.9777.0837.19
Other Current Assets
834.2211.35.9511.916.296.11
Total Current Assets
1,7111,8551,9562,0702,135332.22
Property, Plant & Equipment
298.85216.42170.14133.92134.98137.95
Long-Term Investments
231010---
Other Intangible Assets
17.3917.7718.2118.7118.186.71
Long-Term Deferred Tax Assets
21.3523.8131.2227.9418.5112.96
Long-Term Deferred Charges
47.846.6110.789.695.64.93
Other Long-Term Assets
2.0721.9821.4838.4521.0518.33
Total Assets
2,1212,1522,2182,2992,333513.1

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
67.6636.2328.2617.9420.923.64
Accrued Expenses
14.9315.7614.8211.8218.0321.21
Current Portion of Leases
9.191017.6713.8713.958.69
Current Income Taxes Payable
0.54-0.011.345.014.52
Current Unearned Revenue
5.195.855.024.194.8111.61
Other Current Liabilities
1.491.291.390.971.322.11
Total Current Liabilities
99.0169.1267.1750.1264.0271.78
Long-Term Leases
38.8445.648.7559.4469.278.34
Long-Term Unearned Revenue
1.411.550.520.87--
Long-Term Deferred Tax Liabilities
-----3.21
Other Long-Term Liabilities
0.270.55----
Total Liabilities
139.53116.83116.44110.43133.22153.33

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
69.9270.1870.1870.1870.1852.63
Additional Paid-In Capital
1,9701,9761,9631,9501,940208.13
Retained Earnings
-47.330.5778.36167.86190.198.82
Treasury Stock
-11.96-11.96-10.35---
Comprehensive Income & Other
0.660.270.150.180.180.19
Shareholders' Equity
1,9822,0352,1022,1882,200359.77
Total Liabilities & Equity
2,1212,1522,2182,2992,333513.1

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
48.0355.6166.4273.3183.1587.04
Net Cash (Debt)
677.431,6541,7351,8171,814102.36
Net Cash Growth
-9.77%-4.64%-4.50%0.16%1671.86%9.09%
Net Cash Per Share
9.7723.6124.8725.4631.792.56
Filing Date Shares Outstanding
69.7769.7769.8370.1870.1852.63
Total Common Shares Outstanding
69.7769.7769.8370.1870.1852.63
Working Capital
1,6121,7861,8892,0202,071260.44
Book Value Per Share
28.4029.1630.1031.1931.356.84
Tangible Book Value
1,9642,0172,0832,1702,182353.06
Tangible Book Value Per Share
28.1528.9129.8430.9231.096.71
Machinery
-95.278.9364.4459.6642.2
Construction In Progress
-132.2274.9531.2617.7321.16